When
developing a new compound for a successful launch, biopharmaceutical
companies commonly assess the market opportunity. DDI’s Market
Opportunity Assessment includes analysis in each of the following
areas:
- Market landscape
- Market needs and goals
- Competitor analysis
- Product profile assessment
Uniquely, DDI probes to understand the types of patients
with whom prescribers will first try your emerging brand,
what they will look for in these first patients, and what
will compel prescribers to incorporate your brand into
their limited armamentarium.
Sample Market Opportunity Assessment
ISSUE: Your
company is looking at an in-licensing opportunity. It is
a compound that has completed Phase II clinical development.
CHALLENGE: The drug class is different than any internal brand.
Business Development needs a commercial perspective
before the next licensing meeting in 5 weeks.
ACTIONS: DDI
is commissioned, reviews the data, and works with your team
to develop a product profile, interview selected investigators,
and study coordinators, KOLs and practitioners.
RESULTS: DDI
provides a description of the market landscape, identifies
key competitors with their relative strengths and weaknesses,
identifies the target market segment for launch, and provides
guidance on commercial milestones based on commercial success
factors. |
